Jan van der Laan
Universitair docent / gast
- Naam
- Dr. J.W. van der Laan
- Telefoon
- +31 6 5275 6424
- jw.vd.laan@cbg-meb.nl
Voor meer informatie zie de Engelse profielpagina
Promovendi
Universitair docent / gast
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Toxicology
- Braak S.J. ter, Siezen C.L., Lee J.S., Rao P., Voorhoeve C., Ruppin E., Laan J.W. van der & Water B. van de (2017), Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production, Breast cancer research 19: 14.
- Braak S.J. ter, Siezen C.L.E., Speksnijder E.N., Koedoot E., Steeg H. ter, Salvatori D.C.F., Water B. van de & Laan J.W. van der (2015), Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53(R270H/+)WAPCre mouse model, Breast cancer research 17: 14.
- Dempster M., Siezen K., Braak S.J. ter, Brink W.J. van den, Emerenciana A., Bellanti F., Duijnhoven R.G., Kwa M. & Laan J.W. van der (2015), Carcinogenicity of Biopharmaceuticals. In: Graziano M.J. & Jacobson-Kram D. (red.), Genotoxicity and Carcinogenicity Testing of Pharmaceuticals. Cham: Springer International Publishing. 125-157.
- Bronsveld H.K., Braak B. ter, Karlstad O., Vestergaard P., Starup-Linde J., Bazelier M.T., Bruin M.L. de, Boer A. de, Siezen C.L.E., Water B. van de, Laan J.W. van der & Schmidt M.K. (2015), Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence, Breast cancer research 17: 100.
- Braak B. ter, Wink S., Koedoot E., Pont C., Siezen C., Laan J.W. van der & Water B. van de (2015), Alternative signaling network activation through different insulin receptor family members caused by pro-mitogenic antidiabetic insulin analogues in human mammary epithelial cells, Breast cancer research 17: 97.